{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:49:36Z","timestamp":1791575376864,"version":"4.3.4"},"reference-count":107,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.jns.2018.02.005","type":"journal-article","created":{"date-parts":[[2018,2,5]],"date-time":"2018-02-05T12:27:18Z","timestamp":1517833638000},"page":"35-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"special_numbering":"C","title":["Tardive syndromes"],"prefix":"10.1016","volume":"389","author":[{"given":"Daniel","family":"Savitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Jankovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2018.02.005_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2018.02.008","article-title":"The nosology of tardive syndromes","author":"Frei","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2018.02.005_bb0010","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1600-0447.1964.tb05731.x","article-title":"Neurological symptoms in pharmacotherapy of psychoses","volume":"40","author":"Faurbye","year":"1964","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jns.2018.02.005_bb0015","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.schres.2006.01.024","article-title":"Stereotypy in schizophrenia","volume":"84","author":"Morrens","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jns.2018.02.005_bb0020","series-title":"Principles and Practice of Movement Disorders","author":"Fahn","year":"2011"},{"key":"10.1016\/j.jns.2018.02.005_bb0025","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/jnnp-2014-309098","article-title":"Movement disorders in catatonia","volume":"86","author":"Wijemanne","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2018.02.005_bb0030","series-title":"Diagnostic and Statistical Manual of Mental Disorders","article-title":"Medication-induced movement disorders and other adverse effects of medication","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.jns.2018.02.005_bb0035","series-title":"Principles and Practice of Movement Disorders","first-page":"415","author":"Fahn","year":"2011"},{"key":"10.1016\/j.jns.2018.02.005_bb0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.parkreldis.2016.11.012","article-title":"Oculogyric crises: etiology, pathophysiology and therapeutic approaches","volume":"36","author":"Barow","year":"2017","journal-title":"Parkinsonism Relat. Disord."},{"issue":"Suppl. 1","key":"10.1016\/j.jns.2018.02.005_bb0045","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1016\/S1353-8020(13)70027-0","article-title":"Acute and subacute drug-induced movement disorders","volume":"20","author":"Burkhard","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"issue":"Suppl. 1","key":"10.1016\/j.jns.2018.02.005_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1092852915000838","article-title":"The clinical challenges of akathisia","volume":"20","author":"Lohr","year":"2015","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jns.2018.02.005_bb0055","first-page":"1","article-title":"An update on tardive dyskinesia: from phenomenology to treatment","volume":"3","author":"Waln","year":"2013","journal-title":"Tremor Other Hyperkinet Mov."},{"key":"10.1016\/j.jns.2018.02.005_bb0060","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s40265-016-0568-1","article-title":"Drug-induced dyskinesia, part 2: treatment of tardive dyskinesia","volume":"76","author":"Vijayakumar","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.jns.2018.02.005_bb0065","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1177\/2045125315601343","article-title":"Mirtazapine for antipsychotic-induced acute akathisia: a systematic review and meta-analysis of randomized placebo-controlled trials","volume":"5","author":"Raharaj","year":"2015","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.jns.2018.02.005_bb0070","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ajp.2017.05.004","article-title":"Neuroleptic malignant syndrome: a neuro-psychiatric emergency: recognition, prevention, and management","volume":"29","author":"Velamoor","year":"2017","journal-title":"Asian J. Psychiatr."},{"issue":"1","key":"10.1016\/j.jns.2018.02.005_bb0075","doi-asserted-by":"crossref","DOI":"10.4088\/PCC.17r02185","article-title":"Neuroleptic malignant syndrome: diagnosis and management","volume":"20","author":"Ware","year":"2018","journal-title":"Prim Care Companion CNS Disord."},{"key":"10.1016\/j.jns.2018.02.005_bb0080","series-title":"Tardive Dyskinesia: Motor System Impairments, Cognition and Everyday Functioning","first-page":"1","author":"Strassnig","year":"2017"},{"key":"10.1016\/j.jns.2018.02.005_bb0085","doi-asserted-by":"crossref","first-page":"488","DOI":"10.2174\/138161210790361461","article-title":"Third generation antipsychotic drugs: partial agonism or receptor functional selectivity?","volume":"16","author":"Mailman","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jns.2018.02.005_bb0090","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/2045125316672136","article-title":"Brexpiprazole and cariprazine: distinguishing two new atypical antipsychotics from the original dopamine stabilizer aripiprazole","volume":"7","author":"Frankel","year":"2017","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.jns.2018.02.005_bb0095","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4088\/PCC.v07n0602","article-title":"Atypicality of atypical antipsychotics","volume":"7","author":"Farah","year":"2005","journal-title":"Prim Care Companion J. Clin. Psychiatry"},{"key":"10.1016\/j.jns.2018.02.005_bb0100","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/head.12712","article-title":"Movement disorders from the use of metoclopramide and other antiemetics in the treatment of migraine","volume":"56","author":"Wijemanne","year":"2016","journal-title":"Headache"},{"key":"10.1016\/j.jns.2018.02.005_bb0105","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/0091270007312258","article-title":"Metoclopramide, an increasingly recognized cause of tardive dyskinesia","volume":"48","author":"Kenney","year":"2008","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jns.2018.02.005_bb0110","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/ncpgasthep0442","article-title":"Drug insight: from disturbed motility to disordered movement\u2014a review of the clinical benefits and medicolegal risks of metoclopramide","volume":"3","author":"Pasricha","year":"2006","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jns.2018.02.005_bb0115","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1080\/14656566.2016.1258063","article-title":"Dopamine depleters in the treatment of hyperkinetic movement disorders","volume":"17","author":"Jankovic","year":"2016","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.jns.2018.02.005_bb0120","first-page":"162","article-title":"Medication-induced tardive dyskinesia: a review and update","volume":"17","author":"Cornett","year":"2017"},{"key":"10.1016\/j.jns.2018.02.005_bb0125","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/pcn.12270","article-title":"Tardive dyskinesia (syndrome): current concept and modern approaches to its management","volume":"69","author":"Lerner","year":"2015","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jns.2018.02.005_bb0130","first-page":"1","article-title":"American psychiatric association, steering committee on practice guidelines, practice guideline for the treatment of patients with schizophrenia, second edition","volume":"161","author":"Lehman","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jns.2018.02.005_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7573\/dic.212259","article-title":"Tardive dyskinesia in patients treated with atypical antipsychotics: case series and brief review of etiologic and treatment considerations","volume":"3","author":"Kim","year":"2014","journal-title":"Drugs Context"},{"key":"10.1016\/j.jns.2018.02.005_bb0140","doi-asserted-by":"crossref","first-page":"e264","DOI":"10.4088\/JCP.16r10832","article-title":"Tardive dyskinesia prevalence in the period of second-generation antipsychotic use: a meta-analysis","volume":"78","author":"Carbon","year":"2017","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jns.2018.02.005_bb0145","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/mds.23402","article-title":"Tardive dyskinesia and other movement disorders secondary to aripiprazole","volume":"26","author":"Pe\u00f1a","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2018.02.005_bb0150","doi-asserted-by":"crossref","first-page":"69","DOI":"10.9758\/cpn.2014.12.1.69","article-title":"A case of aripiprazole induced tardive dyskinesia in a neuroleptic-na\u00efve patient with two years of follow up","volume":"12","author":"Goyal","year":"2014","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.jns.2018.02.005_bb0155","first-page":"102","article-title":"Tardive dyskinesia and covert dyskinesia with aripiprazole: a case series","volume":"11","author":"Patra","year":"2016"},{"key":"10.1016\/j.jns.2018.02.005_bb0160","series-title":"C. Description, Case Report A Case of Aripiprazole-induced Tardive Dyskinesia With Dramatic Evolution","author":"Heitzmann","year":"2016"},{"key":"10.1016\/j.jns.2018.02.005_bb0165","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/pgmj.2010.103234","article-title":"Spectrum of tardive syndromes: clinical recognition and management","volume":"87","author":"Bhidayasiri","year":"2011","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.jns.2018.02.005_bb0170","doi-asserted-by":"crossref","first-page":"282","DOI":"10.5334\/tohm.217","article-title":"Reversibility of tardive dyskinesia syndrome","volume":"4","author":"Vinuela","year":"2014","journal-title":"Tremor Other Hyperkinet Mov."},{"key":"10.1016\/j.jns.2018.02.005_bb0175","first-page":"1","article-title":"Tardive syndromes are rarely reversible after discontinuing dopamine receptor blocking agents: experience from a university-based movement disorder clinic","volume":"4","author":"Zutshi","year":"2014","journal-title":"Tremor Other Hyperkinetic Mov."},{"key":"10.1016\/j.jns.2018.02.005_bb0180","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1093\/brain\/121.11.2053","article-title":"The natural history of tardive dystonia. A long-term follow-up study of 107 cases","volume":"121","author":"Kiriakakis","year":"1998","journal-title":"Brain"},{"key":"10.1016\/j.jns.2018.02.005_bb0185","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1192\/bjp.157.4.585","article-title":"Predictors of improvement in tardive dyskinesia following discontinuation of neuroleptic medication","volume":"157","author":"Glazer","year":"1990","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jns.2018.02.005_bb0190","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/mds.25107","article-title":"Tardive dyskinesia is caused by maladaptive synaptic plasticity: a hypothesis","volume":"27","author":"Teo","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2018.02.005_bb0195","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archpsyc.1982.04290040080014","article-title":"Research diagnoses for tardive dyskinesia","volume":"39","author":"Schooler","year":"1982","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jns.2018.02.005_bb0200","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1176\/ajp.135.11.1321","article-title":"Withdrawal syndromes associated with antipsychotic drugs","volume":"135","author":"Gardos","year":"1978","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jns.2018.02.005_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1176\/ajp.151.12.1","article-title":"Practice guideline for the treatment of patients with bipolar disorder","volume":"151","author":"A.P.A.","year":"1994","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jns.2018.02.005_bb0210","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/01.pra.0000400269.68160.e6","article-title":"Evaluation of the routine clinical use of the brief psychiatric rating scale (BPRS) and the abnormal involuntary movement scale (AIMS)","volume":"17","author":"Bark","year":"2011","journal-title":"J. Psychiatr. Pract."},{"key":"10.1016\/j.jns.2018.02.005_bb0215","series-title":"ECDEU Assessment Manual for Psychopharmacology: Revised","first-page":"534","author":"Guy","year":"1976"},{"key":"10.1016\/j.jns.2018.02.005_bb0220","series-title":"Neural Mechanism in Disorders of Movement","article-title":"Neural mechanisms in disorders of movement","author":"Fahn","year":"1989"},{"key":"10.1016\/j.jns.2018.02.005_bb0225","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1212\/WNL.43.5.937","article-title":"Tardive stereotypy and other movement disorders in tardive dyskinesias","volume":"43","author":"Stacy","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2018.02.005_bb0230","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1002\/mds.22102","article-title":"Pain and denture condition in edentulous orodyskinesia: comparisons with tardive dyskinesia and control subjects","volume":"23","author":"Blanchet","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2018.02.005_bb0235","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1750-1172-6-68","article-title":"Neuroacanthocytosis syndromes","volume":"6","author":"Jung","year":"2011","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.jns.2018.02.005_bb0240","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00002826-199506000-00001","article-title":"Tardive syndromes and other drug-induced movement disorders","volume":"18","author":"Jankovic","year":"1995","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.jns.2018.02.005_bb0245","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2054-7072-1-7","article-title":"Upper facial chorea in Huntington disease","volume":"1","author":"Fekete","year":"2014","journal-title":"J. Clin. Mov. Disord."},{"key":"10.1016\/j.jns.2018.02.005_bb0250","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7167452","article-title":"Tardive dyskinesia, oral parafunction, and implant-supported rehabilitation","author":"Lumetti","year":"2016","journal-title":"Case Rep. Dent."},{"key":"10.1016\/j.jns.2018.02.005_bb0255","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/mds.870080224","article-title":"Stereotyped hand clasping: an unusual tardive movement disorder","volume":"8","author":"Kaneko","year":"1993","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2018.02.005_bb0260","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1600-0447.1986.tb02717.x","article-title":"Respiratory irregularity and tardive dyskinesia. A prevalence study","volume":"73","author":"Yassa","year":"1986","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jns.2018.02.005_bb0265","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1378\/chest.105.1.203","article-title":"Respiratory dysrhythmias in patients with tardive dyskinesia","volume":"105","author":"Wilcox","year":"1994","journal-title":"Chest"},{"key":"10.1016\/j.jns.2018.02.005_bb0270","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00004850-199903000-00010","article-title":"Antipsychotic-induced life-threatening \u201cesophageal dyskinesia\u201d","volume":"14","author":"Horiguchi","year":"1999","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jns.2018.02.005_bb0275","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1136\/jnnp-2015-311693","article-title":"Unusual tremor syndromes: know in order to recognise","volume":"87","author":"Ure","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2018.02.005_bb0280","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1097\/JCP.0b013e3182683903","article-title":"Rabbit syndrome following discontinuation of paliperidone in a patient with schizoaffective disorder","volume":"32","author":"Liang","year":"2012","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jns.2018.02.005_bb0285","first-page":"44","article-title":"Risperidone-induced rabbit syndrome: an unusual movement disorder","volume":"78","author":"Sansare","year":"2012","journal-title":"N. Y. State Dent. J."},{"key":"10.1016\/j.jns.2018.02.005_bb0290","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00005053-196207000-00009","article-title":"Chronic involuntary movements induced by phenothiazines","volume":"135","author":"Druckman","year":"1962","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.jns.2018.02.005_bb0295","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1212\/WNL.32.12.1335","article-title":"Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs","volume":"32","author":"Burke","year":"1982","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2018.02.005_bb0300","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/mds.870010305","article-title":"Natural history and treatment of tardive dystonia","volume":"1","author":"Kang","year":"1986","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2018.02.005_bb0305","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1176\/ajp.148.8.1055","article-title":"A review of 32 cases of tardive dystonia","volume":"148","author":"Wojcik","year":"1991","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jns.2018.02.005_bb0310","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.schres.2007.09.010","article-title":"The course of tardive dystonia in Afro Caribbean patients, a population-based study: the Curacao extrapyramidal syndromes study: VII","volume":"98","author":"van Harten","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jns.2018.02.005_bb0315","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/mds.20122","article-title":"Fracture of the odontoid process complicating tardive dystonia","volume":"19","author":"Konrad","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2018.02.005_bb0320","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/jnnp.68.2.186","article-title":"Tardive and idiopathic oromandibular dystonia: a clinical comparison","volume":"68","author":"Tan","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2018.02.005_bb0325","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/mds.870020207","article-title":"Life-threatening tardive dyskinesia caused by metoclopramide","volume":"2","author":"Samie","year":"1987","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2018.02.005_bb0330","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00002826-199702000-00009","article-title":"Life-threatening dysphagia following prolonged neuroleptic therapy","volume":"20","author":"Hayashi","year":"1997","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.jns.2018.02.005_bb0335","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0920-9964(97)00058-3","article-title":"The inter-relationships of tardive dyskinesia, parkinsonism, akathisia and tardive dystonia: the Cura\u00e7ao extrapyramidal syndromes study II","volume":"26","author":"van Harten","year":"1997","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jns.2018.02.005_bb0340","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1176\/ajp.144.7.895","article-title":"Clinical forms of severe tardive dyskinesia","volume":"144","author":"Gardos","year":"1987","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jns.2018.02.005_bb0345","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/YIC.0b013e32834aa924","article-title":"Tardive Tourette-like syndrome","volume":"26","author":"Fountoulakis","year":"2011","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jns.2018.02.005_bb0350","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1176\/ajp.140.5.611","article-title":"Late-onset akathisia-an indicant of covert dyskinesia: two case reports","volume":"140","author":"Braude","year":"1983","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jns.2018.02.005_bb0355","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1056\/NEJM197807272990420","article-title":"Tardive dyskinesia may be only akathisia","volume":"299","author":"Fahn","year":"1978","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2018.02.005_bb0360","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/ana.410130420","article-title":"Persistent akathisia following neuroleptic withdrawal","volume":"13","author":"Weiner","year":"1983","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2018.02.005_bb0365","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0010-440X(82)90084-0","article-title":"Akathisia, pseudoakathisia and tardive dyskinesia: clinical examples","volume":"23","author":"Munetz","year":"1982","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.jns.2018.02.005_bb0370","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/mds.870040208","article-title":"Tardive akathisia: an analysis of clinical features and response to open therapeutic trials","volume":"4","author":"Burke","year":"1989","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2018.02.005_bb0375","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/archpsyc.1985.01790320042006","article-title":"Akathisia variants and tardive dyskinesia","volume":"42","author":"Barnes","year":"1985","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jns.2018.02.005_bb0380","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1016\/S1353-8020(13)70028-2","article-title":"Tardive dyskinesia syndromes: current concepts","volume":"20","author":"Aquino","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"issue":"2","key":"10.1016\/j.jns.2018.02.005_bb0385","first-page":"220","article-title":"Leg stereotypy disorder","volume":"87","author":"Jankovic","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2018.02.005_bb0390","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2017-317057","article-title":"Leg stereotypy syndrome: phenomenology and prevalence","author":"Lotia","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2018.02.005_bb0395","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/mds.870020408","article-title":"Tardive myoclonus","volume":"2","author":"Little","year":"1987","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2018.02.005_bb0400","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0140-6736(87)92042-3","article-title":"Tardive myoclonus","volume":"329","author":"Tominaga","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2018.02.005_bb0405","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/0006-3223(90)90048-7","article-title":"Postural myoclonus associated with long-term administration of neuroleptics in schizophrenic patients","volume":"27","author":"Fukuzako","year":"1990","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jns.2018.02.005_bb0410","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/mds.870070110","article-title":"Tardive tremor","volume":"7","author":"Stacy","year":"1992","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2018.02.005_bb0415","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/mds.10227","article-title":"Tardive tremor due to metoclopramide","volume":"17","author":"Tarsy","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2018.02.005_bb0420","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-11-2011-5156","article-title":"Sensory trick with metoclopramide-associated tardive tremor","volume":"2012","author":"Shprecher","year":"2012","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.jns.2018.02.005_bb0425","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1136\/jnnp-2013-307316","article-title":"Alleviating manoeuvres (sensory tricks) in cervical dystonia","volume":"85","author":"Patel","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2018.02.005_bb0430","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/acn.12009","article-title":"De novo tardive Tourette-like syndrome after prolonged combination depot and oral neuroleptic therapy","volume":"25","author":"Yogaratnam","year":"2013","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.jns.2018.02.005_bb0435","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jocrd.2014.03.005","article-title":"Progress in research on Tourette syndrome","volume":"3","author":"Black","year":"2014","journal-title":"J. Obsessive Compuls. Relat. Disord."},{"key":"10.1016\/j.jns.2018.02.005_bb0440","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2217\/nmt.13.78","article-title":"Differential diagnosis of Huntington's disease: what the clinician should know","volume":"4","author":"Cardoso","year":"2014","journal-title":"Neurodegener. Dis. Manag."},{"key":"10.1016\/j.jns.2018.02.005_bb0445","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1212\/WNL.35.3.432","article-title":"Metoclopramide-induced phantom dyskinesia","volume":"35","author":"Jankovic","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2018.02.005_bb0450","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1176\/ajp.135.7.865a","article-title":"Abnormal gaits in tardive dyskinesia","volume":"135","author":"Simpson","year":"1978","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jns.2018.02.005_bb0455","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1600-0447.1989.tb01301.x","article-title":"Functional impairment in tardive dyskinesia: medical and psychosocial dimensions","volume":"80","author":"Yassa","year":"1989","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jns.2018.02.005_bb0460","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1600-0447.1990.tb03065.x","article-title":"Gait disorders in tardive dyskinesia","volume":"82","author":"Lauterbach","year":"1990","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jns.2018.02.005_bb0465","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.clineuro.2007.09.013","article-title":"Tardive gait","volume":"110","author":"Kuo","year":"2008","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.jns.2018.02.005_bb0470","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/mds.10202","article-title":"Clinical correlates of the pathology underlying parkinsonism: a population perspective","volume":"17","author":"Bower","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2018.02.005_bb0475","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/mds.20748","article-title":"[123 I]-EP\/CIT SPECT imaging for distinguishing drug-induced Parkinsonism from Parkinson's disease","volume":"21","author":"Loberboym","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2018.02.005_bb0480","first-page":"178","article-title":"Loss of dopamine neuron terminals in antipsychotic-treated schizophrenia; relation to tardive dyskinesia","volume":"44","author":"Seeman","year":"2013"},{"key":"10.1016\/j.jns.2018.02.005_bb0485","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/13554790802613033","article-title":"Tardive parkinsonism in a bipolar patient: post-mortem examination supports a physiological rather than pathological dysfunction","volume":"15","author":"Won","year":"2008","journal-title":"Neurocase"},{"key":"10.1016\/j.jns.2018.02.005_bb0490","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/jnnp-2017-315873","article-title":"Early-onset drug-induced parkinsonism after exposure to offenders implies nigrostriatal dopaminergic dysfunction","volume":"89","author":"Chung","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2018.02.005_bb0495","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/mds.26467","article-title":"Neuroleptic-induced Parkinsonism: clinicopathological study","volume":"31","author":"Shuaib","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2018.02.005_bb0500","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF01538282","article-title":"Neurological consequences of psychotropic drug withdrawal in schizophrenic children","volume":"3","author":"Polizos","year":"1973","journal-title":"J. Autism Child. Schizophr."},{"key":"10.1016\/j.jns.2018.02.005_bb0505","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1586\/ern.10.58","article-title":"Tardive dyskinesia and withdrawal emergent syndrome in children","volume":"10","author":"Mejia","year":"2010","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.jns.2018.02.005_bb0510","series-title":"Recent Advances in Clinical Neurology","article-title":"The tardive dyskinesias","author":"Fahn","year":"1984"},{"key":"10.1016\/j.jns.2018.02.005_bb0515","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/nrneurol.2015.86","article-title":"Dopa-responsive dystonia-clinical and genetic heterogeneity","volume":"11","author":"Wijemanne","year":"2015","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jns.2018.02.005_bb0520","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/mds.26910","article-title":"Oculogyric crises: a review of phenomenology, etiology, pathogenesis, and treatment","volume":"32","author":"Slow","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2018.02.005_bb0525","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1212\/WNL.39.11.1434","article-title":"Tardive oculogyric crises","volume":"39","author":"Fitzgerald","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2018.02.005_bb0530","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1474-4422(13)70213-8","article-title":"Sensory aspects of movement disorders","volume":"13","author":"Patel","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2018.02.005_bb0535","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1212\/WNL.44.11.2115","article-title":"Oral and genital tardive pain syndromes","volume":"44","author":"Ford","year":"1994","journal-title":"Neurology"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X18300637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X18300637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T09:09:03Z","timestamp":1603789743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X18300637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":107,"alternative-id":["S0022510X18300637"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2018.02.005","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tardive syndromes","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2018.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}